Europe pharmaceutical manufacturing industry market was valued at $2.84 billion in 2022 and will grow by 8.6% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...

GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix ...

Stocks across Asia lost ground on Monday as worries about Chinese AI company DeepSeek reverberated. The company's discounted R1 model knocked tech stocks, sending the Nikkei ( ^N225) in Japan 0.9% ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in tandem thanks to advancements in technology and a growing body of research on ...

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

Investing.com - European stock markets closed lower Monday, starting the new week on a downbeat note with investors fretting about the state of the global economy and the likely policy responses. At ...

Sales of Apple's iPhone dipped in 2024, with the tech giant losing some of its market share last year, research indicated. Preliminary results from Counterpoint Research's market pulse showed that ...

GSK (GSK), St James’s Place (STJ), Oxford Nanopore Technologies ... fell 19.1 per cent on the back of softer trading in Germany and France. The Americas, Asia Pacific and UK also reported double-digit ...